Prevalence and timing of authorized generics in the US market

DrugPatentWatch – Pharmaceutical and Biotechnology Business Intelligence - Ein Podcast von DrugPatentWatch

Kategorien:

A recent study explores the landscape of authorized generics in the United States pharmaceutical market. Authorized generics are brand-name drugs that are marketed without their original branding. The article sheds light on the trends, launch timing, and characteristics of these authorized generics in comparison to traditional generics. Authorized Generics Launch Trends Many authorized generics are […] Source

Visit the podcast's native language site